Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Pharmacogenomic Testing in Psychiatry: Ready for Primetime?
Gopalkumar Rakesh
, Calvin R. Sumner
, Jeanne Leventhal Alexander
, Lawrence S. Gross
, Janet Pine
, Andrew Slaby
,
Amir Garakani
, David Baron
Friedman Brain Institute
Icahn School of Medicine at Mount Sinai
Psychiatry
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacogenomic Testing in Psychiatry: Ready for Primetime?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacogenetic Testing
100%
Psychiatry
100%
Clinical Decision-making
75%
Clinical Application
50%
Randomized Controlled Trial
25%
Initial Treatment
25%
Treatment Plan
25%
Treatment Decisions
25%
Biological Basis
25%
On-state Current
25%
Clinical Vignette
25%
Clinical Validity
25%
Clinical Psychiatry
25%
Analytical Validity
25%
Current Relevance
25%
Medicine and Dentistry
Psychiatry
100%
Pharmacogenetic Testing
100%
Clinical Decision Making
75%
Clinician
25%
Randomized Controlled Trial
25%
Resuscitation
25%
Clinical Psychiatry
25%
Neuroscience
Decision-Making
100%
Psychiatry
100%
Randomized Controlled Trial
33%
Clinical Psychiatry
33%
Nursing and Health Professions
Pharmacogenetic Testing
100%
Decision-Making
75%
Resuscitation
25%
Efficacy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenomics
100%
Randomized Controlled Trial
25%